Sarah Murawski, MPAS

Sarah Murawski, MPAS, physician assistant in Medicine at the Vanderbilt University Medical Center, discusses how telemedicine can impact the use of chimeric antigen receptor (CAR) T-cell therapy in patients with cancer at the Association of Community Cancer Centers (ACCC) National Oncology Conference.

CAR T-cell therapy is still new. Murawski says we don&rsquo;t know a lot about these agents, but telemedicine will be essential and provide more patients with access to this treatment. Currently, CAR T-cell therapy is not offered at every institution.

Videos

Sarah Murawski, MPAS, discusses how telemedicine can impact the use of chimeric antigen receptor T-cell therapy in patients with cancer at the Association of Community Cancer Centers National Oncology Conference.

Sarah Murawski, MPAS | Authors

Articles

Telemedicine Improves Accessibility of CAR T-Cell Therapy